All
  • All
  • Insight
  • Research Services
  • Preclinical CRO
  • Animal Resource Bank
CN
中文 English
CRISPR Screen library screening

CRISPR Screen library screening

CRISPR‑screen library screening is currently the core technological platform for high‑throughput gene‑function studies and target discovery. Aniphe BioLab has established an integrated tripartite screening system—In Vivo, In Vitro, and In Silico—that progresses sequentially from computational‑modeling predictions, through high‑throughput cell‑based primary screens, to in vivo functional validation, enabling genome‑wide, multidimensional, and systematic gene‑function profiling. This approach rapidly identifies disease‑relevant genes, drug targets, immune‑regulatory genes, and pathogenic host factors, significantly enhancing both research‑screening efficiency and the rate of translational outcomes.

In Vivo Screen

In Vivo Screen

We offer a systematic in vivo screening service, encompassing efficacy evaluation and biomarker analysis across multiple disease‑specific animal models. This supports the identification of active drug candidates, dose‑finding studies, and pharmacological validation, thereby accelerating translational research from in vitro to in vivo settings.

View Details
In Vitro Screen

In Vitro Screen

We offer in vitro screening services based on cell-based assays and biochemical experiments, covering drug activity assessment, mechanistic studies, and preliminary toxicity screening, helping clients rapidly evaluate the research potential of candidate molecules at an early stage.

View Details
In Silico Library Screening

In Silico Library Screening

Alternatively, leveraging molecular docking, virtual screening, and computational chemistry models, large-scale compound libraries can be rapidly analyzed computationally to prioritize candidate molecules, thereby supporting early-stage drug discovery and optimization.

View Details
< 1 >